Publications & Presentations

Publications & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:
Improvements in Productivity and Disability With INP104 as Assessed by the Migraine Disability Assessment Scale (MIDAS): Results From the Phase 3 STOP 301 Study

Presented at the PAINWEEK Conference, September 6-9, 2022 Authors: Christina Treppendahl, FNP-BC, AQH, MHD; Dawn C. Buse, PhD; Robert Vann, PhD; Christopher Fitzpatrick, PhD; Michelle Murphy, PhD; Stephen B. Shrewsbury, MBChB; Sheena K. Aurora, MD Introduction: As part of the…

READ MORE

Exploratory Efficacy of INP104 in Patients Using Concomitant Preventive Migraine Medications´┐╝

Exploratory Efficacy of INP104 in Patients Using Concomitant Preventive Migraine Medications Authors: Jihan Grant, MD; Robert Vann, PhD; Christopher Fitzpatrick, PhD; Stephen B. Shrewsbury, MB ChB; Sheena K. Aurora, MD Introduction: The exploratory efficacy of INP104 as an acute therapy for…

READ MORE

Early Prediction of Response to INP104 for the Acute Treatment of Migraine

Presented at the PAINWEEK Conference, September 6-9, 2022 Authors: Sara Sacco, MD, FAHS; Robert Vann, PhD; Sutapa Ray, PhD; Stephen B. Shrewsbury, MBChB; Sheena K. Aurora, MD Introduction: Some patients may cycle through many acute therapies for migraine before achieving…

READ MORE